Literature DB >> 910743

Vitamin B6 deficiency in cancer patients.

C Potera, D P Rose, R R Brown.   

Abstract

The plasma pyridoxal phosphate concentration was determined in 30 cases of early breast cancer, 21 patients with locally recurrent disease, and 43 patients with systemic metastases. The two groups of advanced breast cancer had significantly lower plasma pyridoxal phosphate levels than 36 healthy women of similar age. Urinary 4-pyridoxic acid excretion was normal in breast cancer. Plasma pyridoxal phosphate concentrations were also reduced in 34 women with widespread cancer derived from primary sites other than breast, but were normal in 39 with early disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 910743     DOI: 10.1093/ajcn/30.10.1677

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  5 in total

Review 1.  [Pathogenesis and therapy of malnutrition in oncology].

Authors:  G Ollenschläger
Journal:  Z Ernahrungswiss       Date:  1982-06

2.  Perinatal hypophosphatasia: tissue levels of vitamin B6 are unremarkable despite markedly increased circulating concentrations of pyridoxal-5'-phosphate. Evidence for an ectoenzyme role for tissue-nonspecific alkaline phosphatase.

Authors:  M P Whyte; J D Mahuren; K N Fedde; F S Cole; E R McCabe; S P Coburn
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

3.  Markedly increased circulating pyridoxal-5'-phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism.

Authors:  M P Whyte; J D Mahuren; L A Vrabel; S P Coburn
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

4.  Magnesium (and trace substance) deficiencies in the pathogenesis of cancer.

Authors:  M S Seelig
Journal:  Biol Trace Elem Res       Date:  1979-12       Impact factor: 3.738

5.  Association of vitamin B6, vitamin B12 and methionine with risk of breast cancer: a dose-response meta-analysis.

Authors:  W Wu; S Kang; D Zhang
Journal:  Br J Cancer       Date:  2013-08-01       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.